Treatment of IgA Nephropathy According to Renal Lesions
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to IgA Nephropathy
Related studies linked through entity extraction aliases.
Registry of IgA Nephropathy in Chinese Children
- Status
- RECRUITING
- Phase
- N/A
IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
- Status
- UNKNOWN
- Phase
- PHASE4
IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Atacicept in IgA Nephropathy
- Status
- TERMINATED
- Phase
- PHASE2
Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Biomarkers for the Progression of IgA Nephropathy
- Status
- COMPLETED
- Phase
- N/A
Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy
- Status
- COMPLETED
- Phase
- NA
The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients
- Status
- COMPLETED
- Phase
- N/A
Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy
- Status
- SUSPENDED
- Phase
- NA
Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy
- Status
- WITHDRAWN
- Phase
- PHASE2
Acthar on Proteinuria in IgA Nephropathy Patients
- Status
- WITHDRAWN
- Phase
- PHASE4
Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy
- Status
- UNKNOWN
- Phase
- PHASE4
Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f.
- Status
- UNKNOWN
- Phase
- PHASE3
Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy
- Status
- COMPLETED
- Phase
- PHASE2
BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy
- Status
- WITHDRAWN
- Phase
- PHASE3
Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath
- Status
- UNKNOWN
- Phase
- NA
The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients
- Status
- COMPLETED
- Phase
- NA